Abpro Holdings Revenue

In the year 2024, Abpro Holdings had annual revenue of $183.00K with 50.00% growth.

Revenue (ttm)

$183.00K

Revenue Growth

+50.00%

P/S Ratio

25.59

Revenue / Employee

$12,200

Employees

Market Cap

10.75M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	183.00K	61.00K	50.00%
Dec 31, 2023	122.00K	-1.91M	-93.99%
Dec 31, 2022	2.03M	1.55M	322.71%
Dec 31, 2021	480.00K	-1.72M	-78.19%
Dec 31, 2017	2.20M	516.00K	30.62%
Dec 31, 2016	Pro	Pro	Pro
Sep 30, 2010	Pro	Pro	Pro

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
UnitedHealth Group	410.06B
Johnson & Johnson	89.33B
Merck & Co.	63.92B
AbbVie	57.37B
AstraZeneca	54.98B
Novartis AG	53.22B
Eli Lilly and Company	49.00B
Novo Nordisk	43.92B

Revenue Rankings

ABP News

15 days ago - Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager - GlobeNewsWire
6 weeks ago - Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 - GlobeNewsWire
2 months ago - Abpro Statement on the Departure of Former CEO Ian Chan - GlobeNewsWire
5 months ago - Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing - GlobeNewsWire

More News